Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Anžič Jožica) .

1 - 8 / 8
First pagePrevious page1Next pageLast page
1.
Evolving strategies in the treatment of childhood rhabdomyosarcoma : Slovenian experience
Živa Pohar-Marinšek, Jožica Anžič, Berta Jereb, 2001, original scientific article

Abstract: Background. Neoadjuvant chemotherapy (Cht) has changed the treatment of rhabdomyosarcoma (RMS) in children. The purpose of our study was to review thechildren treated for RMS between 1974 and 1996. Patients and methods. Fifty-one children, 1-15 years old, were included. Primary sites of tumour were: head and neck 15, orbit 6, genitourinary 12, extremity 9, torso 5 and paratesticular 4. Twelve patients were in stage 1, 10 in stage II, 26 in stage111 and 3 in stage IV. Of 43 histologically confirmed RMS 25 were embryonal, 13 alveolar, 1 botryoid, 1 spindle cell and 3 sarcoma NOS. In 8 patients, only fine needle aspiration biopsy (FNAB) was available. All patients had Cht, 29 neoadjuvant, 20 had surgery first, 40 had irradiation (RT), 2 stage IV patients had bone marrow transplant (ABMT). Multidrug Cht varied: VCR, AMD, and cyclophosphamide (VAC) were used in the 1970s, with Adriablastine (T2), methotrexat (MTX) and/or other drugs (T6, T11) in the 1980s; and in the 1990s, cyclophosphamide was replaced by ifosfamide (VAIA). The treatment was started with Cht in orbital and head and neck tumours and inthe majority of genitourinary tumours, but surgery was first in paratesticular and in the majority of extremity tumours. Results. The 3 patients with stage IV disease died. Of those with localised tumour, 34 (70%) were alive and well 5 years after treatment, 80% stage I, 75% stage II and 61%stage III. One patient died of heart failure, 3 of Cht toxicity and 1 of intereurrent disease. Conclusions. (Abstract truncated at 2000 characters)
Published in DiRROS: 26.01.2024; Views: 124; Downloads: 28
.pdf Full text (177,30 KB)

2.
3.
Kaj so nas naučili bolni otroci?
Jožica Anžič, 2006, published professional conference contribution

Keywords: onkologija, otroci, bolni otroci
Published in DiRROS: 30.03.2020; Views: 1311; Downloads: 393
.pdf Full text (399,52 KB)

4.
Zdravljenje s citostatiki in podporno zdravljenje v otroški onkologiji
Jožica Anžič, 1995, published scientific conference contribution

Published in DiRROS: 04.02.2020; Views: 1323; Downloads: 364
.pdf Full text (684,13 KB)

5.
Znaki raka pri otroku
Jožica Anžič, 1998, published professional conference contribution

Published in DiRROS: 17.09.2019; Views: 1640; Downloads: 430
.pdf Full text (415,77 KB)

6.
Zdravljenje s kemoterapijo
Jožica Anžič, Majda Benedik-Dolničar, 1998, published professional conference contribution

Published in DiRROS: 17.09.2019; Views: 1735; Downloads: 398
.pdf Full text (590,90 KB)

7.
Okvara srca po zdravljenju raka v otroštvu
Veronika Velenšek Prestor, Uroš Mazić, Peter Rakovec, D. Demšar, Ciril Kržišnik, Berta Jereb, Majda Benedik-Dolničar, Jožica Anžič, 2006, original scientific article

Published in DiRROS: 31.08.2018; Views: 2827; Downloads: 727
.pdf Full text (1,31 MB)

8.
Otroška onkologija v Sloveniji
Jožica Anžič, Berta Jereb, 1998, professional article

Published in DiRROS: 31.08.2018; Views: 2733; Downloads: 618
.pdf Full text (1015,55 KB)

Search done in 0.32 sec.
Back to top